The worldwide flow cytometry market size was esteemed at USD 6.3 billion out of 2020 and is relied upon to extend at an accumulated yearly development rate (CAGR) of 8.9% from 2021 to 2027. Factors like the high predominance of focused illnesses and expanding R&D interests in biotechnology, clinical, and life science research are required to altogether fuel market development over the gauge time frame.
Flow cytometry is normally utilized for the conclusion of disease and immunodeficiency. The expanding predominance of these infections is one of the components expected to drive the flow cytometry market over the conjecture time frame. Likewise, antagonistic impacts of chemotherapy and radiation treatment in malignancy therapy have expanded the inclination for autologous and allogeneic undifferentiated cell treatments by doctors, accordingly emphatically affecting the development of this market. As indicated by World Cancer Research Fund International (WCRF) information, around 18 million malignancy cases were recorded in 2018 worldwide. Out of these, around 17,036,901 new cases were analyzed around there. A similar source detailed around 437,033 recently analyzed leukemia cases in the year 2018. Flow cytometry is helpful in the determination and arrangement of leukemia and works with recognizing lymphoid and myeloid leukemia.... Read more